Groowe Groowe / Newsroom / BMBL
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMBL News

Bumble Inc. Class A Common Stock

Bumble Inc. to Announce First Quarter 2026 Financial Results on May 5, 2026

businesswire.com
BMBL

Miltenyi Biotec's Antibodies Division Leverages Bioz Badges to Deliver Powerful Publication Visibility

accessnewswire.com
BMBL

CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Unresectable/Metastatic Hepatocellular Carcinoma

businesswire.com
BMBL

VIRTUAL CARE IS HERE TO STAY: BLUE SHIELD OF CALIFORNIA'S VIRTUAL BLUE PROGRAM DELIVERS IMPROVED ACCESS, MORE AFFORDABLE HEALTH CARE, HIGH PATIENT SATISFACTION

prnewswire.com
BMBL

Bending Spoons renueva su programa de becas tecnológicas para mujeres con un compromiso de 100.000 euros

businesswire.com
EVR BMBL BRCC

Endometrics Wins First Prize in NIH RADx Tech ACT ENDO Challenge

businesswire.com
BMBL

Form 8-K

sec.gov
BMBL

Bumble Inc. Announces Fourth Quarter and Full Year 2025 Results

businesswire.com
BMBL

Global Telehealth Market is Projected to Cross the USD 2 Trillion Mark by 2034, Driven by Digital Healthcare Transformation | DelveInsight

prnewswire.com
TDOC CSCO PHG IBM MDT AMWL GEHC HPQ DOX ISRG BMBL ADMA FLEX INTC GOOG MSFT AMZN NVDA AAPL TSLA JNJ PFE ABBV BMY MRK XRAY SYK BDX LULU ROST ULTA COST MCHP ON ADI TXN QCOM AMD SIRI CMCSA VZ T MU AMAT KLAC LRCX WDC SE BABA JD NTES PDD IQ BIDU FOX FOXA NFLX DIS CMG MCD SBUX YUM CVS EL ORCL CRM NOW ADBE INTU PAYX ADP MA V AXP GS JPM BAC WFC MS CME ICE SCHW AMGN GILD REGN BIIB AZN NVS SNY TEVA CPRT ALGN EXPE BKNG MAR HLT IHG WYNN LVS MGM EXAS ACAD ALKS VRTX CRSP EDIT NTLA NBIX ALNY BMRN IDXX ZBRA HON ETR NEE DUK SO XOM CVX SHEL GOOGL META TMUS AVGO MRVL NXPI INFY DELL HPE LEN BRK.B BRK.A UNH CI CNC ELV HCA EBS TTWO EA NTDOY SONY GE BA GD LMT RTX NOC CAT DE AGCO CNH IRTC HOLX TNDM PODD RMD MASI SNOW DDOG PANW FTNT CRWD OKTA SNPS CDNS

Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)

globenewswire.com
JUNS BMBL NVO